SCHEMBL28056977

SCHEMBL28056977

COc1cc(Nc2cc(Nc3ccc(F)c(Cl)c3)ncn2)ccc1N

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.55
▸ ERBB2 P04626 2/20 0.55
▸ AURKA O14965 1/20 0.55
▸ INSR P06213 1/20 0.55
▸ FBP1 P09467 1/20 0.55
▸ PDGFRB P09619 1/20 0.55
▸ FLT4 P35916 1/20 0.55
▸ KDR P35968 1/20 0.55
▸ CLK1 P49759 1/20 0.55
▸ EPHB4 P54760 1/20 0.55
▸ TEK Q02763 1/20 0.55
▸ AURKB Q96GD4 1/20 0.55
▸ MAPK1 P28482 1/20 0.50
▸ TDO2 P48775 1/20 0.47
▸ GRM1 Q13255 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ RAF1 P04049 1/20 0.47
▸ BRAF P15056 1/20 0.47
▸ ERBB3 P21860 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777464 0.89 EGFR (0.61) EGFRERBB2AURKAINSRFBP1
SCHEMBL2203223 0.85 EGFR (0.55) EGFRERBB2AURKAINSRFBP1
SCHEMBL7771232 0.82 MEN1 (0.70) EGFRERBB2AURKAINSRFBP1
SCHEMBL1095277 0.80 MAPK1 (0.61) EGFRERBB2AURKAINSRFBP1
SCHEMBL7777468 0.79 EGFR (0.74) EGFRERBB2AURKAINSRFBP1
SCHEMBL19089515 0.79 GALR2 (0.49) EGFRERBB2AURKAINSRFBP1
SCHEMBL7775667 0.79 EGFR (0.60) EGFRMAPK1GRM1ERBB3
SCHEMBL19089675 0.78 EGFR (0.49) EGFRERBB2AURKAINSRFBP1
SCHEMBL1387327 0.78 APP (0.62) EGFRERBB2AURKAINSRFBP1
SCHEMBL19089519 0.77 EGFR (0.59) EGFRERBB2PDGFRBKDREPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105367503-A HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS INC 2016-03-02 — — CN disclosed
Send feedback